Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

NCT06820424 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Collaborators